ALTERATION OF TREATMENT CHOICES AND THE VISUAL PROGNOSIS FOR DIABETIC MACULAR EDEMA IN THE ERA OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR DRUGS: Analysis of the STREAT-DME 2 Study.

Both baseline BCVA ( P for trend = 0.011; Figure 1 A [black square]) and final BCVA ( P for trend < 0.001; Figure 1 A [white square]) showed a significant trend toward improvement by year.

also in 9,775 other papers

The proportion of “improved” eyes that increased by >0.3 logMAR over the 2 years did not differ to a statistically significant extent between the groups ( P = 0.360 [ANOVA]; Figure 1 C [black rhombus]), whereas the proportion of “worsened” eyes that decreased by >0.3 logMAR showed a decreasing trend ( P for trend < 0.001; Figure 1 C [white rhombus]).

also in 47,180 other papers